153 related articles for article (PubMed ID: 17398032)
1. Perineural invasion is a marker for pathologically advanced disease in localized prostate cancer.
Lee IH; Roberts R; Shah RB; Wojno KJ; Wei JT; Sandler HM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1059-64. PubMed ID: 17398032
[TBL] [Abstract][Full Text] [Related]
2. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
3. Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer.
Beard CJ; Chen MH; Cote K; Loffredo M; Renshaw AA; Hurwitz M; D'Amico AV
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):19-24. PubMed ID: 14697416
[TBL] [Abstract][Full Text] [Related]
4. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
Miyake H; Sakai I; Harada K; Eto H; Hara I
Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
[TBL] [Abstract][Full Text] [Related]
5. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
[TBL] [Abstract][Full Text] [Related]
6. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Wong WW; Schild SE; Vora SA; Halyard MY
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
8. Perineural invasion in prostatic carcinoma treated with radical prostatectomy: the role of TR systematic biopsy.
Passavanti G; Pizzuti V; Costantini FM; Nucciotti R; Stumpo M; Paolini R
Arch Ital Urol Androl; 2007 Mar; 79(1):23-5. PubMed ID: 17484400
[TBL] [Abstract][Full Text] [Related]
9. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy.
Yu HH; Song DY; Tsai YY; Thompson T; Frassica DA; DeWeese TL
Urology; 2007 Jul; 70(1):111-6. PubMed ID: 17656219
[TBL] [Abstract][Full Text] [Related]
10. Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy.
DeLancey JO; Wood DP; He C; Montgomery JS; Weizer AZ; Miller DC; Jacobs BL; Montie JE; Hollenbeck BK; Skolarus TA
Urology; 2013 Feb; 81(2):354-7. PubMed ID: 23374801
[TBL] [Abstract][Full Text] [Related]
11. Investigating association of perineural invasion on prostate biopsy with Gleason score upgrading at prostatectomy: A multi-institutional analysis.
Barsky AR; Kraus RD; Carmona R; Santos PMG; Li C; Schwartz LE; Ballas LK; Vapiwala N
Cancer Med; 2020 May; 9(10):3383-3389. PubMed ID: 32187859
[TBL] [Abstract][Full Text] [Related]
12. Perineural invasion in prostate needle biopsy: Prognostic value on radical prostatectomy and active surveillance.
Ramos N; Macedo A; Rosa J; Carvalho M
Arch Ital Urol Androl; 2020 Dec; 92(4):. PubMed ID: 33348961
[TBL] [Abstract][Full Text] [Related]
13. Effects of perineural invasion in prostate needle biopsy on tumor grade and biochemical recurrence rates after radical prostatectomy.
Celik S; Bozkurt O; Demir O; Gurboga O; Tuna B; Yorukoglu K; Aslan G
Kaohsiung J Med Sci; 2018 Jul; 34(7):385-390. PubMed ID: 30063011
[TBL] [Abstract][Full Text] [Related]
14. Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients.
Caster JM; Falchook AD; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):244-51. PubMed ID: 25841621
[TBL] [Abstract][Full Text] [Related]
15. Colour Doppler ultrasonography for detecting perineural invasion (PNI) and the value of PNI in predicting final pathological stage: a prospective study of men with clinically localized prostate cancer.
Kravchick S; Cytron S; Peled R; Ben-Dor D; Kravchenko Y
BJU Int; 2003 Jul; 92(1):28-31. PubMed ID: 12823378
[TBL] [Abstract][Full Text] [Related]
16. Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy.
Pierorazio PM; Lin BM; Mullins JK; Hyndman ME; Schaeffer EM; Han M; Partin AW; Pavlovich CP
Urol Oncol; 2013 Jul; 31(5):589-94. PubMed ID: 21664838
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
19. Percentage of positive biopsy cores: a better risk stratification model for prostate cancer?
Huang J; Vicini FA; Williams SG; Ye H; McGrath S; Ghilezan M; Krauss D; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1141-8. PubMed ID: 22099043
[TBL] [Abstract][Full Text] [Related]
20. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
